相关实验视频

Updated: Sep 12, 2025

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

作为预后指标的C-反应蛋白/白蛋白比率预测手术干预的新生儿与死性肠球炎:一个前性队列研究

Ahsan Ali Ghauri¹, Zubair Shaukat¹, Aziz Ahmad Chattha¹

¹Pediatric Surgery, The Children's Hospital, University of Child Health Sciences, Lahore, PAK.

|August 5, 2025

概括

C反应蛋白/白蛋白比率 (CRP/白蛋白) 有效地预测了患有死角性肠球炎 (NEC) 的新生儿的手术需求和死亡率. 在三天内监测其趋势,为及时干预提供了卓越的预测价值.

科学领域:

新生儿手术新生儿手术
儿科胃肠病学儿科胃肠病学
生物标志物研究的研究.

背景情况:

死性肠球炎 (NEC) 在新生儿中具有显著的发病率和死亡率.
由于依赖晚期的临床或放射学指标,对NEC进行手术干预的早期预测受到阻碍.
在手术决策过程中,C-反应蛋白与白蛋白比率 (CRP/白蛋白) 可以提供有关炎症和营养状况的动态见解.

研究的目的:

评估CRP/白蛋白比率在预测NEC新生儿手术干预和死亡率方面的预后能力.
评估CRP/白蛋白比率在疾病前三天的时间进展的有用性.

主要方法:

一项前性队列研究,涉及66名被诊断患有贝尔病I-IIIa NEC的新生儿.
连续三天每天测量C反应蛋白 (CRP) 和白蛋白水平,以计算CRP/白蛋白比率.
使用ROC分析分析CRP/白蛋白比率趋势 (下降,上升,稳定,可变) 和与结果 (手术,死亡率) 的相关性.

主要成果:

新生儿CRP/白蛋白比率上升的趋势显示,手术干预率 (89.5%) 和死亡率 (26.3%) 显著上升 (p < 0.001).
CRP/白蛋白比率显示了外科手术的优异预测准确性,曲线下的面积 (AUC) 值在第1-3天超过0.92.
与单次测量相比,CRP/白蛋白比率的连续监测提供了更好的预后价值,在第2天和第3天的最佳切断值显示了>85%的灵敏度和特异性.

结论:

CRP/白蛋白比率是一种可靠,具有成本效益的生物标志物,用于早期识别风险较高的新生儿进行手术干预和NEC的不良结果.
监测CRP/白蛋白比率的时间进展可以提高预测准确度,并支持对NEC管理的及时临床决策.

关键词:

专辑蛋白比率是指专辑蛋白比率.c反应性蛋白质是什么死性肠球炎 (necrotizing enterocolitis) 是一种致死性肠球炎的疾病.新生儿炎症新生儿炎症新生儿重症监护室新生儿重症监护室新生儿手术新生儿手术预后生物标志物预后生物标志物这是一种外科手术干预.

更多相关视频

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Serum Studies: Renal Function Tests

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...